L. Roy Papp & Associates’s ResMed RMD Stock Holding History

L. Roy Papp & Associates’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.06M	Buy	18,069 +1,569	+10%	+$391K	0.47%	44
2025 Q4	$3.97M	Buy	16,500 +2,848	+21%	+$728K	0.44%	46
2025 Q3	$3.74M	Buy	13,652 +2,816	+26%	+$769K	0.42%	46
2025 Q2	$2.8M	Buy	10,836 +3,191	+42%	+$761K	0.33%	55
2025 Q1	$1.71M	Sell	7,645 -330	-4%	-$77K	0.21%	73
2024 Q4	$1.82M	Sell	7,975 -165	-2%	-$39.7K	0.21%	69
2024 Q3	$1.99M	Sell	8,140 -220	-3%	-$49.2K	0.24%	69
2024 Q2	$1.6M	Sell	8,360 -110	-1%	-$22.3K	0.19%	77
2024 Q1	$1.68M	Sell	8,470 -410	-5%	-$75.1K	0.2%	78
2023 Q4	$1.53M	Sell	8,880 -70	-0.8%	-$10.8K	0.19%	78
2023 Q3	$1.32M	Hold	8,950	–	–	0.18%	78
2023 Q2	$1.96M	Hold	8,950	–	–	0.25%	70
2023 Q1	$1.96M	Hold	8,950	–	–	0.26%	70
2022 Q4	$1.86M	Hold	8,950	–	–	0.26%	71
2022 Q3	$1.95M	Hold	8,950	–	–	0.3%	65
2022 Q2	$1.88M	Hold	8,950	–	–	0.27%	71
2022 Q1	$2.17M	Sell	8,950 -100	-1%	-$24.2K	0.27%	69
2021 Q4	$2.36M	Hold	9,050	–	–	0.27%	69
2021 Q3	$2.38M	Hold	9,050	–	–	0.3%	66
2021 Q2	$2.23M	Hold	9,050	–	–	0.28%	68
2021 Q1	$1.76M	Sell	9,050 -54	-0.6%	-$10.8K	0.25%	75
2020 Q4	$1.94M	Hold	9,104	–	–	0.22%	77
2020 Q3	$1.56M	Buy	9,104 +407	+5%	+$75.2K	0.2%	77
2020 Q2	$1.67M	Hold	8,697	–	–	0.24%	71
2020 Q1	$1.28M	Hold	8,697	–	–	0.23%	82
2019 Q4	$1.35M	Hold	8,697	–	–	0.19%	85
2019 Q3	$1.18M	Hold	8,697	–	–	0.18%	89
2019 Q2	$1.06M	Hold	8,697	–	–	0.17%	93
2019 Q1	$904K	Hold	8,697	–	–	0.16%	86
2018 Q4	$990K	Sell	8,697 -47	-0.5%	-$5.04K	0.21%	81
2018 Q3	$1.01M	Hold	8,744	–	–	0.18%	86
2018 Q2	$906K	Hold	8,744	–	–	0.17%	89
2018 Q1	$861K	Hold	8,744	–	–	0.16%	94
2017 Q4	$741K	Sell	8,744 -466	-5%	-$38.5K	0.15%	95
2017 Q3	$709K	Sell	9,210 -323	-3%	-$24.7K	0.15%	89
2017 Q2	$742K	Sell	9,533 -161	-2%	-$11.5K	0.16%	91
2017 Q1	$698K	Hold	9,694	–	–	0.16%	90
2016 Q4	$602K	Sell	9,694 -47	-0.5%	-$2.88K	0.14%	99
2016 Q3	$631K	Hold	9,741	–	–	0.15%	97
2016 Q2	$616K	Hold	9,741	–	–	0.15%	97
2016 Q1	$563K	Hold	9,741	–	–	0.13%	104
2015 Q4	$523K	Hold	9,741	–	–	0.13%	101
2015 Q3	$496K	Buy	9,741 +150	+2%	+$8.07K	0.12%	100
2015 Q2	$541K	Hold	9,591	–	–	0.12%	106
2015 Q1	$688K	Hold	9,591	–	–	0.15%	95
2014 Q4	$538K	Hold	9,591	–	–	0.12%	106
2014 Q3	$473K	Hold	9,591	–	–	0.11%	104
2014 Q2	$486K	Sell	9,591 -1,600	-14%	-$79.3K	0.11%	105
2014 Q1	$500K	Sell	11,191 -4,396	-28%	-$197K	0.12%	100
2013 Q4	$734K	Hold	15,587	–	–	0.16%	85
2013 Q3	$823K	Hold	15,587	–	–	0.2%	82
2013 Q2	$703K	Buy	+15,587	New	+$740K	0.17%	83

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

L. Roy Papp & Associates's RMD Position: Q1 2026 in Review

L. Roy Papp & Associates increased its ResMed (RMD) stake by 9.5% in Q1 2026, buying an estimated $391K and bringing the position to 18,069 shares worth $4.06M. The position accounts for 0.47% of the portfolio, ranked #44.

L. Roy Papp & Associates first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

L. Roy Papp & Associates held 18,069 shares of ResMed worth $4.06M as of Q1 2026.
L. Roy Papp & Associates bought 1,569 ResMed shares in Q1 2026, an estimated $391K.
ResMed made up 0.47% of L. Roy Papp & Associates's portfolio in Q1 2026, its #44 holding.
L. Roy Papp & Associates first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on L. Roy Papp & Associates's 13F filing for Q1 2026, filed 14 Apr 2026.